Exploring the Safety and Efficacy of Low-dose Ketamine Infusions for Pain Control in Acute Burn Injury

Withdrawn before enrolling · Phase 4

Conditions studied: Pain

In brief

The purpose of this study is to identify the optimal dosing strategy for low-dose ketamine infusions in adult acute burn injury patients when used with usual pain medications.

Key facts

Study ID

NCT03095222

Run by

University of Kansas Medical Center

People needed

0

Starts

2017-04-01

Expected to finish

2018-05-24

Last updated by the study team

2018-10-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Acute burn injury comprising 10-30% of total body surface. Burns severity may include second or third degree burns
• Burn injury must have occurred within 72 hours of enrollment and randomization
• Subjects may be opioid-naïve or opioid non-naïve
• Anticipated stay in the burn unit is greater than 4 days, which is typically the minimum length of stay for patients with this level of burn injury

You may not qualify if…

• Burn injury older than 72 hours
• Acute burn injury comprising >30% total body surface
• Patients who are intubated
• Patients who have contraindication to ketamine administration

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.